Keywords: Genzyme, Mozobil, Wales, UK, NICE

Genzyme gets backing for Mozobil in Wales, as UK’s NICE takes political sabbatical

Article | 09 April 2010

Print This

US biotechnology firm Genzyme has welcomed the decision by the All Wales Medicines Strategy Group (AWMSG) to recommend its Mozobil ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in